Abstract:Juan-Min Zha, 1, &ast Mei Zhang, 1, &ast Tao Wang, 2, &ast Hua-Shan Li, 1, 2, &ast Quan-Yao Ban, 1, &ast Mei Liu, 1 Xue-Xue Jiang, 1 Shi-Ying Guo, 2 Jing Wang, 2 Ya-Ru Zhou, 2 Yu-Hong Liu, 2 Wei-Qi He, 1, 2 Hong Xu 1 1 Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China; 2 Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Suda (CAM-SU) Genomic Resource Center, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei-Qi He; Hong Xu, Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China, Tel +86-512-6588-3545, Email ; Objective: This cross-sectional study aimed to explore the association of overweight and inflammatory indicators with breast cancer risk in Chinese patients. Methods: Weight, height, and peripheral blood inflammatory indicators, including white blood cell count (WBC), neutrophil count (NE), lymphocyte count (LY), platelet count (PLT) and the concentration of hypersensitivity C-reactive protein (hsCRP), were collected in 383 patients with benign breast lumps (non-cancer) and 358 patients with malignant breast tumors (cancer) at the First Affiliated Hospital of Soochow University, China, from March 2018 to July 2020. Body mass index (BMI), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) were determined according to the ratio equation. The correlations among overweight, inflammatory indicators, and the proportion of non-cancer or cancer cases were analyzed. Results: BMI is associated with an increased breast cancer risk. Compared with non-cancer patients, the average WBC count, NE count, NLR, and level of hsCRP were significantly higher in cancer patients. The level of hsCRP was closely associated with the size of malignant breast tumors. Conclusion: We conclude that overweight and high levels of hsCRP may serve as putative risk factors for malignant breast tumors in Chinese women. Keywords: breast cancer, body mass index, overweight, chronic inflammation, inflammatory indicator Breast cancer is the most prevalent invasive cancer in women and the leading cause of cancer-related deaths in women around the world. 1–3 In China, breast cancer is also the most common cancer in women. In 2022, breast cancer will be China's fourth leading cause of death in women. 4 Therefore, it is of great significance to determine the putative-risk factors for breast cancer. Numerous studies aimed at enhancing the survival rate and prognosis of breast cancer patients have been reported. For instance, a novel approach has been developed to identify subtype-specific network biomarkers for predicting breast cancer survivability, achieving remarkable classification performance, and demonstrating potential clinical utility for personalized treatment strategies. 5 Moreover, an innovative method that combines high-dimensional embedding and residual neural networks has been introduced to accurately classify breast cancer Nottingham Prognostic Index (NPI) classes while identifying crucial prognostic biomarkers. 6 It is well known that obesity has a huge impact on human health. The proportion of obese people who suffer from metabolic diseases such as diabetes, hypertension, hyperlipidemia and sleep apnea syndrome is significantly higher than that of nonobese people. 7 In recent years, many studies have shown that obesity is related to the occurrence of malignant tumors such as colorectal cancer, pancreatic cancer, bladder cancer and endometrial cancer. 8–14 Meanwhile, an increasing number of studies have revealed that obesity plays a significant role in promoting the onset and development of malignant tumors, poor prognosis, and drug resistance to anticancer therapy. 15,16 The production of insulin and insulin-like growth factors, adipocytokines, the inflammatory response, hypoxia, and oxidative stress are potential risk factors for obesity-related cancers. 17–23 Obesity is linked to an increased incidence of breast cancer, a poor prognosis, an increased chance of disease recurrence, and increased mortality in postmenopausal women. 24–26 Comparing to non-obese patients, obese breast cancer patients exhibit significantly poorer overall survival rates. Additionally, obese breast cancer -Abstract Truncated-

Sicca complex and cholestatic jaundice in two members of a family caused by thiabendazole.

The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China.

Population-attributable Risk Estimates for Breast Cancer in Chinese Females

Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China

Association Of Body Size And Fat Distribution With Risk Of Breast Cancer Among Chinese Women

The Impact of Reproductive Factors on the Risk of Breast Cancer by ER/PR and HER2: A Multicenter Case-Control Study in Northern and Eastern China

Abstract P4-03-31: Lifestyle factors are associated with breast cancer risk in women biopsied for benign breast diseases in China: 10-year results of a multi-center, hospital-based, case-control study

L2RLab: Integrated Experimenter Environment for Learning to Rank

Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women.

The Association Between Metabolic Abnormality and Endometrial Cancer: a Large Case-Control Study in China.

Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause

Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women

Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.

Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank

A Case-Control Study on Risk Factors of Breast Cancer in China

Interaction between body mass index and family history of cancer on the risk of female breast cancer

Association of Overweight and Inflammatory Indicators with Breast Cancer: A Cross-Sectional Study in Chinese Women

Obesity Or Overweight Is Associated With Worse Pathological Response To Neoadjuvant Chemotherapy Among Chinese Women With Breast Cancer

Sex disparity in the association between metabolic-anthropometric phenotypes and risk of obesity-related cancer: a prospective cohort study

Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort

Association of overweight and obesity with breast cancer